Caitong International Asset Management Co., LTD Alx Oncology Holdings Inc Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 80 shares of ALXO stock, worth $88. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80
Previous 80
-0.0%
Holding current value
$88
Previous $134,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALXO
# of Institutions
98Shares Held
39.7MCall Options Held
136KPut Options Held
28.8K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$10.7 Million13.33% of portfolio
-
Redmile Group, LLC San Francisco, CA3.69MShares$4.06 Million0.48% of portfolio
-
Tang Capital Management LLC San Diego, CA3.3MShares$3.63 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$2.96 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.5MShares$2.75 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $44.8M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...